51 Lakh people in India are at risk of contracting Chikungunya in the Long Term: Study
- 04 October 2025
- 3 weeks ago
Bharat Biotech Gets SEC Nod to Begin Phase III Trial of Inactivated Chikungunya Vaccine
- 26 September 2025
- 1 month ago
Chikungunya May Affect Central Nervous System As Well As Joints And Lungs
- 18 July 2025
- 3 months ago
Recent News
Roche appoints Nina Schwab-Hautzinger as Head of G...
- 26 October, 2025
Nagaland University inaugurates cancer research la...
- 26 October, 2025
India to Regulate Cell and Gene Therapies Under Dr...
- 26 October, 2025
NEET 2025: WBMCC notifies revised schedule for rou...
- 26 October, 2025
Moderna scraps mRNA vaccine in congenital CMV on t...
- 26 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.



